0001179110-15-001059.txt : 20150120 0001179110-15-001059.hdr.sgml : 20150119 20150120161005 ACCESSION NUMBER: 0001179110-15-001059 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20150116 FILED AS OF DATE: 20150120 DATE AS OF CHANGE: 20150120 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ALERE INC. CENTRAL INDEX KEY: 0001145460 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 043565120 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 51 SAWYER ROAD STREET 2: SUITE 200 CITY: WALTHAM STATE: MA ZIP: 02453 BUSINESS PHONE: 7816473900 MAIL ADDRESS: STREET 1: 51 SAWYER ROAD STREET 2: SUITE 200 CITY: WALTHAM STATE: MA ZIP: 02453 FORMER COMPANY: FORMER CONFORMED NAME: INVERNESS MEDICAL INNOVATIONS INC DATE OF NAME CHANGE: 20010720 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Flakne Carla CENTRAL INDEX KEY: 0001600843 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-16789 FILM NUMBER: 15536093 MAIL ADDRESS: STREET 1: 51 SAWYER ROAD STREET 2: SUITE 200 CITY: WALTHAM STATE: MA ZIP: 02474 4 1 edgar.xml FORM 4 - X0306 4 2015-01-16 0 0001145460 ALERE INC. ALR 0001600843 Flakne Carla 51 SAWYER ROAD, SUITE 200 WALTHAM MA 02453 0 1 0 0 VP, Chief Accounting Officer Common Stock 2014-11-07 5 G 0 E 380 0 D 3011 D Common Stock 2015-01-16 4 M 0 10000 23.15 A 13252 D Common Stock 2015-01-16 4 S 0 10000 42.445 D 3252 D Common Stock 462 I See Footnote Employee Stock Option (Right to Buy) 23.15 2015-01-16 4 M 0 10000 D 2015-12-14 Common Stock 10000 0 D Includes 248 shares acquired under the Alere Inc. Employee Stock Purchase Plan on June 30, 2014. The transactions reported on this Form were made pursuant to a written 10b5-1 trading plan adopted in accordance with SEC Rule 10b5-1. Represents same day exercise and sale of expiring stock options. Includes 241 shares acquired under the Alere Inc. Employee Stock Purchase Plan on December 31, 2014. The price reported is a weighted average price. These shares were sold in approximately 68 separate transactions at prices ranging from $41.81 to $42.82, inclusive. The reporting person hereby undertakes to provide to the SEC, the issuer or any stockholder of the issuer, upon request, the full information regarding the number of shares and prices at which the transaction was effected. Option vested in four equal installments on 12/14/06, 12/14/07, 12/14/08 and 12/14/09. This derivative security does not have a price. These securities are owned by the 2012 Flakne Family Trust, for which the reporting person & her spouse are the trustees. /s/ Jay McNamara, attorney-in-fact 2015-01-20